Ebola surging in Sierra Leone amid lack of treatment centres: U.N

Health workers carry the body of an Ebola virus victim in the Waterloo district of FreetownDAKAR (Reuters) – The number of Ebola cases is surging in Sierra Leone as the country suffers from a lack of treatment centres, while lack of food and basic goods is forcing some people to leave quarantine areas, the United Nations said. The U.N. Mission for Ebola Emergency Response (UNMEER) said in its weekly report that a total of 1,062 people had died in Sierra Leone from the virus, with the outbreak particularly virulent in the western areas around the coastal capital Freetown. Sierra Leone is emerging as the focal point for concern in the worst Ebola outbreak on record. …

Go to Source

U.S. pulls approval for Ranbaxy copies of AstraZeneca, Roche drugs

A general view of the office of Ranbaxy Laboratories is pictured at GurgaonBy Zeba Siddiqui MUMBAI (Reuters) – The U.S. Food and Drug Administration has revoked a tentative approval for India's Ranbaxy Laboratories to make a cheap copy of AstraZeneca's heartburn drug Nexium, after its Indian plants were banned over quality control issues. The FDA has also stripped Ranbaxy of tentative approval and six-month exclusivity for a copy of Roche's antiviral Valcyte, a fresh blow to the Indian company that has been hit by a raft of regulatory bans over poor production quality. The U.S. …

Go to Source

EU scheme commits $350 million for research on Ebola vaccines, tests

Scientists at the National Microbiology Lab in Winnipeg prepare an experimental Ebola vaccine for shipment to the World Health OrganizationBy Ben Hirschler LONDON (Reuters) – The Europe Union and drugmakers pledged on Thursday to invest 280 million euros ($350 million) in Ebola research, with the lion's share going to the testing and manufacture of potential vaccines. The funding will go to projects backed by the Innovative Medicines Initiative (IMI), a public-private scheme jointly paid for by the European Commission and the pharmaceuticals industry. Reuters reported on Oct. 22 that an IMI investment of around 200 million euros was pending. …

Go to Source

Hospira revenue rises 14 percent on higher sales of injectable drugs

(Reuters) – Drugmaker Hospira Inc reported a 14.1 percent rise in quarterly revenue as it charged higher prices and sold more of its injectable drugs. The company’s net income rose to $158.6 million, or 92 cents per share, in the quarter ended Sept. 30 from $1.9 million, or 1 cent per share, a year earlier. The increase was mainly due to a $106.3 million gain on the sale of its clinical surveillance software business, Theradoc. Revenue rose to $1.2 billion from $1 billion. Sales of injectable drugs rose 16.7 percent and accounted for about 55 percent of total sales. …
Go to Source

Ebola surging in Sierra Leone amid lack of treatment centers: U.N.

Health workers spray themselves with chlorine disinfectants after removing the body a woman who died of Ebola virus in the Aberdeen district of FreetownDAKAR (Reuters) – The number of Ebola cases is surging in Sierra Leone as the country suffers from a lack of treatment centers, while lack of food and basic goods is forcing some people to leave quarantine areas, the United Nations said. The U.N. Mission for Ebola Emergency Response (UNMEER) said in its weekly report that a total of 1,062 people had died in Sierra Leone from the virus, with the outbreak particularly virulent in the western areas around the coastal capital Freetown. Sierra Leone is emerging as the focal point for concern in the worst Ebola outbreak on record. …

Go to Source

1 98 99 100 101 102 1,024